Matches in Wikidata for { <http://www.wikidata.org/entity/Q64801545> ?p ?o ?g. }
Showing items 1 to 36 of
36
with 100 items per page.
- Q64801545 description "clinical trial" @default.
- Q64801545 description "ensayu clínicu" @default.
- Q64801545 description "klinisch onderzoek" @default.
- Q64801545 description "клінічне випробування" @default.
- Q64801545 name "Study to Evaluate the Safety and Activity (Including Distribution) of 177Lu-3BP-227 in Subjects With Solid Tumours Expressing Neurotensin Receptor Type 1." @default.
- Q64801545 type Item @default.
- Q64801545 label "Study to Evaluate the Safety and Activity (Including Distribution) of 177Lu-3BP-227 in Subjects With Solid Tumours Expressing Neurotensin Receptor Type 1." @default.
- Q64801545 prefLabel "Study to Evaluate the Safety and Activity (Including Distribution) of 177Lu-3BP-227 in Subjects With Solid Tumours Expressing Neurotensin Receptor Type 1." @default.
- Q64801545 P1050 Q64801545-3D624D76-F32D-4197-BB66-2EBCD62E415A @default.
- Q64801545 P1050 Q64801545-B38A9E34-210D-4DB5-B06B-E946A8FC0106 @default.
- Q64801545 P1132 Q64801545-9C380E5A-52F2-4486-8C1E-DCC35A0EF078 @default.
- Q64801545 P1476 Q64801545-9A531BCF-2EA7-4E8E-8DD1-A5B7A20533B6 @default.
- Q64801545 P17 Q64801545-4686E2D6-036B-4F01-8425-792468B3B228 @default.
- Q64801545 P2899 Q64801545-DEA9D8B7-EC17-42C5-96F3-82DE21D5AC36 @default.
- Q64801545 P3098 Q64801545-302B2BDF-26C1-4B9B-9A34-E70B072BCFFC @default.
- Q64801545 P31 Q64801545-691BE5EC-4317-4969-AAD8-BBF61025D5CE @default.
- Q64801545 P580 Q64801545-FCF8DC61-8433-4BF2-856D-AAC012C44DFA @default.
- Q64801545 P582 Q64801545-547FABB2-E4BF-4D8C-A0D0-D0479B9A9312 @default.
- Q64801545 P6099 Q64801545-A4BCD39C-300A-4583-B69B-6A88568890E3 @default.
- Q64801545 P6099 Q64801545-D81BA0ED-9979-473F-BCD6-87659C2EC24C @default.
- Q64801545 P6153 Q64801545-A2BC5F45-415C-4C1A-B0C3-9FDBA2274C01 @default.
- Q64801545 P8363 Q64801545-8D29F44C-CF48-4D97-8138-D14E7C9BEC86 @default.
- Q64801545 P1050 Q356033 @default.
- Q64801545 P1050 Q549534 @default.
- Q64801545 P1132 "+320" @default.
- Q64801545 P1476 "An International Multicentre, Open-Label First in Human Phase I/II Study to Evaluate the Safety, Tolerability, Biodistribution and Antitumour Activity of 177Lu-3BP-227 for the Treatment of Subjects With Solid Tumours Expressing Neurotensin Receptor 1" @default.
- Q64801545 P17 Q142 @default.
- Q64801545 P2899 "+18" @default.
- Q64801545 P3098 "NCT03525392" @default.
- Q64801545 P31 Q30612 @default.
- Q64801545 P580 "2018-05-03T00:00:00Z" @default.
- Q64801545 P582 "2020-04-07T00:00:00Z" @default.
- Q64801545 P6099 Q42824440 @default.
- Q64801545 P6099 Q5452194 @default.
- Q64801545 P6153 Q2945753 @default.
- Q64801545 P8363 Q78089383 @default.